SARS-CoV-2 (COVID-19) ORF8 antibody
GTX135591
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry
Product group Antibodies
ReactivityVirus
Overview
- SupplierGeneTex
- Product NameSARS-CoV-2 (COVID-19) ORF8 antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:1000-1:10000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.5 mg/ml
- ConjugateUnconjugated
- HostRabbit
- IsotypeIgG
- ReactivityVirus
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Kim IJ, Lee YH, Khalid MM, et al. SARS-CoV-2 protein ORF8 limits expression levels of Spike antigen and facilitates immune evasion of infected host cells. J Biol Chem. 2023,299(8):104955. doi: 10.1016/j.jbc.2023.104955Read this paper
- Arshad N, Laurent-Rolle M, Ahmed WS, et al. SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression. Proc Natl Acad Sci U S A. 2023,120(1):e2208525120. doi: 10.1073/pnas.2208525120Read this paper
- Arshad N, Laurent-Rolle M, Ahmed WS, et al. SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to downregulate MHC-I surface expression. bioRxiv. 2022,:pii: 2022.05.17.492198. doi: 10.1101/2022.05.17.492198.Read this paper
- Li W, Kitsios GD, Bain W, et al. Stability of SARS-CoV-2-Encoded Proteins and Their Antibody Levels Correlate with Interleukin 6 in COVID-19 Patients. mSystems. 2022,7(3):e0005822. doi: 10.1128/msystems.00058-22Read this paper
- Wu X, Xia T, Shin WJ, et al. Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8. mBio. 2022,13(2):e0040222. doi: 10.1128/mbio.00402-22Read this paper
- Grant SN, Lester HA. Regulation of epithelial sodium channel activity by SARS-CoV-1 and SARS-CoV-2 proteins. Biophys J. 2021,120(14):2805-2813. doi: 10.1016/j.bpj.2021.06.005Read this paper